doi: 10.4049/jimmunol.175.2.1310 Summary Keywords thyroid, COVID-19 vaccine, hyperthyroidism, autoimmune, SARS-CoV-2, Graves disease, inflammatory syndrome, ACE2 Citation Murugan AK and Alzahrani AS (2025) COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves disease
2023 Apr;160:114376
doi: 10.1207/s15327914nc5501_7
Take extra care when measuring out the volume of the dose as this can affect how well the peptide functions in your body
Patients with an underactive thyroid should consult their provider
In addition to improved patient-reported symptom-based outcomes, ARA 290 administration was also associated with a significant increase in corneal small nerve fiber density, changes in cutaneous temperature sensitivity, and an increased exercise capacity as assessed by the 6-minute walk test